From LifeNews...
Abortion advocates in Congress last month floated an amendment that would force an investigation of the FDA's delay on approving the morning after pill for over the counter access. But, they quickly dropped those demands when a pro-life lawmaker floated an amendment to investigate the rapid approval process of the dangerous RU 486 abortion drug at the end of the Clinton administration.
For more, see this brief story.
